ROTEM platelet
Transkript
ROTEM platelet
ROTEM platelet ® with ROTEM®delta ROTEM®platelet supplements the platelet function analysis for ROTEM®– guided peri-operative bleeding management Measures platelet function and aggregation in whole blood samples Single use test reagents for the detection of aggregation disorders Fast and safe handling through touch-screen instructions Proven technologies in one ROTEM®system NEW ROTEM®platelet Proven technologies in one system The ROTEM®platelet measures platelet aggregation in whole blood samples using impedance aggregometry. The new device is run in conjunction with the ROTEM®delta, and is compatible with all existing ROTEM®delta models with serial numbers >2000. The ROTEM ®platelet characteristics are: – – – – Dedicated single use cuvettes with electrodes 2 channels can be used simultaneously (for one patient sample) Measurement time is 6min, while allowing for emergency samples 3 different parameters are available: A6 (amplitude at 6min in Ohm) MS (maximum slope of the aggregation graph in Ohm/min) AUC (area under the curve in Ohm*min) Measurements can be performed on the ROTEM®platelet device while running measurements on the ROTEM ®delta system simultaneously. Single Use Reagents adp-tem ROTEM ®platelet detection principle ® e.g. for the detection of ADP receptor blockage (Clopidogrel) ara-tem ® trap-tem ® Data processing e.g. for the detection e.g. for the detection of cyclooxygenase of GP llb/llla receptor inhibitors (Aspirin ®) antagonists (Abciximab) Reaction curve MS (Ohm/min) A6 (Ohm) AUC (Ohm*min) Resistance between two electrodes is measured After adding aggregation agents the platelets are activated Platelets aggregate on electrodes and increase electrical resistance www.rotem.de [email protected] tem ® Tem International GmbH Martin-Kollar-Strasse 13-15 81829 Munich, Germany T:+49 (0)89 454295-0 F:+49 (0)89 454295-22 © ROTEM®platelet 10/2013 en v002 Contact
Podobné dokumenty
Nestabilní angina pectoris
riziko nízké: farmakoterapie, zátěžový test
a podle jeho výsledku indikace SKG
riziko vysoké: farmakoterapie včetně i.v.
GP IIb/IIIa inhibitoru, urgentní katetrizace a
intervence podle nálezu:
...